AGRANA Beteiligungs-AG (AGRANA) manufactures and markets sugar, starch products from corn, wheat and potatoes, fruit preparations and fruit juice concentrates. The company’s product portfolio includes fodder and fertilizers, bioethanol, betaine for cosmetic and pharma products, and animal feed based on the by-products of sugar and starch production. AGRANA is a leading producer of organic starches manufactured from corn, wheat and potatoes.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

AGRANA is actively engaged in R&D initiatives focused on identifying market and technology trends early, developing targeted product innovations, and creating customized solutions for its clientele. The company emphasizes sustainable and lasting success through its research efforts. Key areas of focus include new technologies, specialty products, and innovative applications for existing products. The company is working on improving the firmness and structural stability of fruit pieces, developing multisensory consumption experiences, and creating new probiotic and heat-stable variants. Additionally, AGRANA is expanding its portfolio with new natural and functional starch products, refining vegetable proteins for various food applications, and developing sustainable non-food starch solutions. The company has 18 local new-product development centers for fruit products. As of February 2026, it had approximately 324 employees in its R&D operations. In FY2026, the company incurred expenses of EUR24.8 million on R&D, which as a percentage of revenue, stood at 0.8%.